F-star Therapeutics, Inc. Stock
Equities
FSTX
US30315R1077
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20-11-19 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20-11-19 |
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |